First-in-Human Trial of the Novel Tuberculosis Vaccine Candidate, H107e/CAF®10b (nTB-01)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT06050356 |
Recruitment Status :
Recruiting
First Posted : September 22, 2023
Last Update Posted : March 18, 2024
|
Sponsor:
Statens Serum Institut
Collaborators:
Aurum Institute
Bill and Melinda Gates Foundation
Leiden University Medical Center
South African Tuberculosis Vaccine Initiative
Information provided by (Responsible Party):
Statens Serum Institut
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Recruiting |
---|---|
Estimated Primary Completion Date : | May 2026 |
Estimated Study Completion Date : | May 2026 |